Revium Rx (RVRC) Debt Ratio (2024 - 2025)

Revium Rx recorded quarterly Debt Ratio of 0.07 in Q4 2025, up 547.81% quarter-over-quarter from 0.01 in Q4 2024, and up 547.81% year-over-year from 0.01 in Q4 2024.

Revium Rx's Debt Ratio history runs 2 years deep, the most recent figure standing at 0.07 for Q4 2025.

  • In Q4 2025, Debt Ratio rose 547.81% year-over-year to 0.07; the TTM figure through Dec 2025 stood at 0.07 (up 547.81% YoY), while the FY2025 annual figure was 0.07, up 547.81% from the prior year.
  • Debt Ratio came in at 0.07 for Q4 2025 at Revium Rx, up from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.07 in Q4 2025 to a low of 0.01 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.40
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.29
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.25
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Revium Rx - - - 0.07

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.07
Dec 31, 2024 0.01